Correlation Between Mineralys Therapeutics, and Century Therapeutics

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Century Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Century Therapeutics.

Diversification Opportunities for Mineralys Therapeutics, and Century Therapeutics

-0.24

Correlation Coefficient

Mineralys Therapeutics,  Century Therapeutics

Very good diversification

The 3 months correlation between Mineralys and Century is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Century Therapeutics go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Century Therapeutics

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.74 times more return on investment than Century Therapeutics. However, Mineralys Therapeutics, Common is 1.35 times less risky than Century Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Century Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  1,241  in Mineralys Therapeutics, Common on August 30, 2024 and sell it today you would earn a total of  70.00  from holding Mineralys Therapeutics, Common or generate 5.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Century Therapeutics

Mineralys Therapeutics,

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Century Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Century Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Century Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Mineralys Therapeutics, and Century Therapeutics

The main advantage of trading using opposite Mineralys Therapeutics, and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.

The idea behind Mineralys Therapeutics, Common and Century Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.